Viewing Study NCT01399918

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:01 AM
Ignite Modification Date: 2026-02-28 @ 11:27 PM
Study NCT ID: NCT01399918
Status: COMPLETED
Last Update Posted: 2022-02-01
First Post: 2011-07-20
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Kidney View
None Everolimus View
None Bevacizumab View
None 10-226 View
None non-clear cell histology View
None Advanced View